Patients 1 and 2 exhibit profound hypotonia, developmental delay, feeding difficulties, early-onset epilepsy, and microcephaly, along with dysmorphic craniofacial features, including cleft palate and flat midface, a manifestation that further supports the role of CRELD1 in craniofacial development. This evidence concerns the gene CRELD1 and epilepsy.